ClinicalTrials.Veeva

Menu
A

Assertive Research Center, LLC | Assertive Research Center, LLC

Research site

Site insights

Top conditions

Top treatments

KarXT
CVL-865

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Bashar Mohsen

Verified by this site

Active trials

3 of 3 total trials
Locations recently updated

A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia (ARISE)

This is a Phase 3, 6-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with schizophrenia with an inadequ...

Enrolling
Schizophrenia
Drug: Xanomeline and Trospium Chloride Capsules
Drug: Placebo

This is a Phase 3, multicenter, 52-week, outpatient, open-label extension (OLE) study to evaluate the long-term safety and tolerability of adjunctive...

Enrolling
Schizophrenia
Drug: Xanomeline and Trospium Chloride Capsules

The purpose of this study is to assess the long-term safety and tolerability of CVL-865 as adjunctive therapy in participants with focal onset seizur...

Active, not recruiting
Seizures
Drug: CVL-865

Trial sponsors

Karuna Therapeutics logo
Cerevel Therapeutics logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems